Medicine
Medicine News
Direct Relief's Corporate Partners Key to Aiding Cyclone Victims
| 5/9/2008 | SANTA BARBARA, Calif., May 9 USNewsire/ -- U.S.corporations providing critical medicines and supplies to help victims ofthe Cyclone Nargis in Myanmar are relying upon their long-time partner,Direct Relief International, to ensure that the aid will reach the peopleand organizations who need it most. "It's important to remember the complete story of the humanitarianeffort di... [Comments] |
| 5/9/2008 | BANGKOK, Thailand, May 9 -- InternationalRescue Committee emergency team members have arrived in Myanmar and fouradditional teams are on standby for deployment to the region as the IRCprepares for a possible outbreak of water-borne diseases in cyclone-ravagedvillages. "Nearly all homes were destroyed in the villages I assessed today andthe survivors have virt... [Comments] |
New Web Site to Raise Awareness for the Myanmar Crisis Has Lofty Goals
| 5/9/2008 | SAN DIEGO, May 9 /- Summary: With the recent devastatingcyclone in Myanmar causing an estimated 100,000 deaths and leaving over amillion people homeless, the need for relief aid is immense. Internetentrepreneurs Sharon Tucci and Steve Jones have launched the MyanmarChallenge, a grassroots effort to award awareness for humanitarian needs,with hopes of filling the need as muc... [Comments] |
| 5/9/2008 | LOS ANGELES, May 9 /- Los Angeles based Operation USA hasdeployed staff already stationed in Asia to assess the needs of what is nowan estimated 7 million people affected by the recent cyclone whichdestroyed or devastated wide swaths of Myanmar (aka Burma), especially inor near Yangon (formerly the capital Rangoon) and throughout its vast ricegrowing delta. The cyclone gene... [Comments] |
| 5/9/2008 | Resolves Allegations of Compliance Matters at Defunct Facility CARSON, Calif., May 9 /- Leiner Health Products Inc.("Leiner" or "the Company") announced today that it has submitted aproposed agreement with the United States Department of Justice to the U.S.Bankruptcy Court in Delaware for approval. The proposed agreement wouldresolve the previously disclosed investigati... [Comments] |
Simuality Joins Efforts for Myanmar Relief
| 5/9/2008 | EVANSTON, Ill., May 9 -- Metaverse developerSimuality LLC has joined the effort to help relieve the unspeakable humansuffering in Myanmar in the wake of Cyclone Nargis. Special donation kioskshave been developed and are being placed in high-traffic locations in thevirtual world of Second Life, with coordination being arranged via theSimuality welcome center on th... [Comments] |
OxyBand Technologies Signs Army Contract
| 5/9/2008 | SAN FRANCISCO, May 9 /- OxyBand Technologies, Inc. todayannounced that it has signed a contract with the United States Army toevaluate the company's patented cutting edge wound healing technology forbattlefield and other military wounds. OxyBand Technologies has developed aproprietary wound dressing that delivers pure oxygen gas into wounds forfaster healing. The OxyBand dr... [Comments] |
Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008
| 5/9/2008 | Coalition for Iraq and Afghanistan Veterans Gather in Virginia toEnvision a Bold Future for Military & Veterans Service Organizations CHANTILLY, Va., May 9 -- As the war in Iraqenters its fifth year and the U.S. death toll climbs above 4,000 andcasualty numbers approach the 30,000 mark, a diverse coalition of militaryand veterans service organizations on the... [Comments] |
Medicine Products
Osteomesh Bioresorbable Implant for Craniofacial Surgery
Description:Osteomesh is a bioresorbable implant used in craniofacial surgery to repair various types of fractures, like the orbital floor fracture and to fill surgical defects. It has interconnected pores which allow rapid saturation with marrow, blood and nutrients, thus providing the patients own cells with chemical signals that are required for bone growth and remodeling. The mesh is malleable and can be...Company:Osteopore InternationalDescription:AMD Now is a forum presenting interactive education on Age- related Macular Degeneration (AMD), AMD diagnosis and treatments, VEGF, aseptic technique and supportive care for patients and caregivers....
Company:ASORN
SWISSBLADE Diamond Surgical Knives
Description:SWISSBLADE disposable surgical knives single-use blades deliver a consistent, sharp, clean cut due to the low friction coefficient achieved with Ziemers proprietary coating technology. SWISSBLADE diamond surgical knives feature top-of-the-line, reusable blades with the proven superior cutting capabilities based on the diamond expertise of Ziemer Group partner Meyco (Biel, Switzerland) an...Company:ZIEMER USA, Inc.
MAXWELL Optical Wavefront Aberrometer
Description:The MAXWELL Optical Wavefront Aberrometer is an innovative diagnostic instrument with a wide range of functions that permit eye care practitioners and researchers to effectively assess all of the wavefront aberrations present in a subjects eye. This remarkable device offers the widest wavefront diagnostic range and functions on more than 99% of subjects. Beyond its superior performance in wavefro...Company:ZIEMER USA, Inc.
ConstaVac CBCII Blood Conservation System
Description:The Stryker CBCII Blood Conservation System provides a safe, simple and economic disposable system for blood reinfusion....Company:Stryker Instruments
Medicine Technology
| 5/9/2008 | TAMPA, Fla., May 9 -- Osteoarthritis is apainful and potentially debilitating condition that affects almost 50million people in the United States. It is caused by deterioration ofcartilage in bone joints. The novel investigational pain medicationtapentadol, a centrally acting oral analgesic, provided significant relieffor patients with joint-disease pain, compared... [Comments] |
| 5/9/2008 | TAMPA, Fla., May 9 -- Many strong acting painmedications have bothersome side effects. These can include nausea andvomiting with short-term use, and constipation with longer, chronic use.Such symptoms can lead patients to discontinue treatment, adding additionalcomplications to pain management for physicians. The novel investigationalmedication tapentadol, a cent... [Comments] |
| 5/9/2008 | Novel Pain Medicine Studied in Patients Following Bunionectomy TAMPA, Fla., May 9 -- Many foot-surgerypatients experience intense pain for several days following removal of abunion, one of the most common foot surgeries. The investigational painmedication tapentadol provided significant relief for patients who had thissurgery, compared to those treated with... [Comments] |
| 5/9/2008 | SEATTLE, May 9 -- The risk of the two majorprostate diseases, cancer and benign prostatic hyperplasia (BPH), can bereduced by changes in lifestyle, such as avoiding smoking, maintaining anormal weight and eating a healthy diet. Alan Kristal, Dr.P.H., associatehead of the Cancer Prevention Program at Fred Hutchinson Cancer ResearchCenter in Seattle, has conducted... [Comments] |
| 5/9/2008 | SAN DIEGO, May 9 /- Ardea Biosciences, Inc.(Nasdaq: RDEA ), a company focused on the discovery and development ofsmall- molecule therapeutics for the treatment of HIV, cancer andinflammatory diseases, including gout, today announced that John W. Beckhas been appointed Senior Vice President, Finance and Operations and ChiefFinancial Officer effective May 27, 2008.... [Comments] |
(Date:5/9/2008)...Supply Flights en Route, NEW YORK, May 9 /PRNewsw...NICEF emergency supplies landed in Yangon today, c...Three more planeloads containing,medicines, emerge...children, are planned over the next three days., ...econd can make a,difference in the life of a Myanm...
(Date:5/9/2008)...enefits regardless of age or education, study find...Having an intellectually demanding job that nurtur...ve abilities during retirement, regardless of inte...y Medical Center study suggests. , "Our society... generations, so we sought to understand how an in...
(Date:5/9/2008)...available for all Minnesotans, MINNEAPOLIS, May 9...smokers can give their mothers and themselves the ...llent opportunity to quit smoking for Mom,or for ...) Services can,help Minnesotans quit smoking, whet...he year. Created by ClearWay Minnesota(SM), QUITPL...
(Date:5/9/2008)...ire-USNewswire/ -- UNFPA, the United,Nations Popul... the urgent,humanitarian concerns of cyclone-affec...Myanmar,s Ayeyarwady and Yangon regions., The a...eal to be,launched by the United Nations today. Te... the cyclone urgently need lifesaving assistance. ...
Breaking Medicine News(10 mins):Health News:UNICEF: 'Every Second Can Make a Difference' to Myanmar's Children; 20% Already Suffering from Diarrhea, Malaria reported 2Health News:UNICEF: 'Every Second Can Make a Difference' to Myanmar's Children; 20% Already Suffering from Diarrhea, Malaria reported 3Health News:Demanding Jobs May Pay Cognitive Dividends in Retirement 2Health News:QUITPLAN(R) Services Can Help Make Mother's Day Smoke-Free 2Health News:$3 Million Requested by UNFPA to Help Women and Girls Displaced by Myanmar Cyclone 2[0] UNICEF: 'Every Second Can Make a Difference' to Myanmar's Children; 20% Already Suffering from Diarrhea, Malaria reported[0] Demanding Jobs May Pay Cognitive Dividends in Retirement[0] QUITPLAN(R) Services Can Help Make Mother's Day Smoke-Free[0] $3 Million Requested by UNFPA to Help Women and Girls Displaced by Myanmar Cyclone
...ommon health problem worldwide. Both osteoarthriti...stiffness in patients. There is no cure for arthri...artilage. A new study could help lead doctors tow...ritis. The research pinpoints the molecular pathwa...
...ds that women who change partners between the birt...deliver pre-term babies with a low birth weight th...ies are also more likely to die within the first y... when researchers take into account the mother’s a...
...r back pain, the right mattress can make a differe...bet is a firm bed mattress, but a new study says t...firm mattresses are more effective at relieving ba...d when patients ask them what type of bed is best ...
... night outlawed tobacco use in the Commonwealth's ... lift the state's ban on Sunday liquor-store sales...ness with a last-minute flurry.// Working until ne... a sales tax "holiday" designed to spur shoppers t...
Other Medicine News:Health News:Changing Partners may put Expectant Mothers at Risk 2Health News:Senate assures ban on smoking 2Health News:Senate assures ban on smoking 3Health News:Senate assures ban on smoking 4... portability & capability together in this user-fr...e & desktop maginifcation., ,With its battery ...magnification device will meet any individual, edu...,Carry it like a briefcase from room to room or ...
...etter. Introducing Disposable Bimanuals. With the...the need for quality single-use bimanuals. Oasis m...disposable bimanuals. Single use bimanuals decreas...y encompass all the advantages of bimanual MICS in...
...can have accurate patient information and secure d...Keep track of patient schedules, manage daily work... PC handheld device. PhysAssist IQ is a handheld P...es not require physicians to change the way they d...
...F40 with its new stand F19 contains three high pre...he one hand to homogenously move the arms and on t...icroscope. The Leica M844 F19 carries the original...footprint and holds the same Two-in-One display an...
Medicine Products:(Date:5/8/2008)...ant improvement in ADHD symptoms in adults, WASHI...LSE: SHP,Nasdaq: SHPGY), the global specialty bio...s of a phase III pivotal study in which VYVANSE,de...eficit Hyperactivity,Disorder (ADHD) symptoms in a... "Adults with ADHD often find it challenging to fo...
(Date:5/8/2008)...Newswire-FirstCall/ -- VION PHARMACEUTICALS,INC. ...nvestigator-sponsored,Phase I/II clinical trial of...1M) in combination with cytarabine in elderly pati...eukemia (AML) and high-risk,myelodysplastic syndro...direction of Ellen K. Ritchie, M.D. at The Weill-C...
(Date:5/8/2008)... New Option for Clinicians Concerned About ... TAMPA, Fla., May 8 /- Alp...ty pharmaceutical company, announced today that tw...n Pain Society annual,meeting demonstrate the effi...ofile of Alpharma Pharmaceuticals, FLECTOR(R) Patc...
(Date:5/7/2008)...re-FirstCall/ -- Shire plc (LSE: SHP,Nasdaq: SHPG..., today,announced findings from a new data analysi...ces with DAYTRANA(TM) (methylphenidate transdermal... with Attention Deficit,Hyperactivity Disorder (AD...t DAYTRANA has an established safety profile and e...
Breaking Medicine Technology:Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 2Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 3Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 4Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 5Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 6Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 7New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 2New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 3New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 5New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 6New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 7Woods Hole Research Center debuts new image mosaic that will strengthen global forest monitoring 1354 1Woods Hole Research Center debuts new image mosaic that will strengthen global forest monitoring 1354 2Woods Hole Research Center debuts new image mosaic that will strengthen global forest monitoring 1354 3Carrington Reports Third Quarter 2007 Results 1969 1Carrington Reports Third Quarter 2007 Results 1969 2Carrington Reports Third Quarter 2007 Results 1969 3Carrington Reports Third Quarter 2007 Results 1969 4Carrington Reports Third Quarter 2007 Results 1969 5Carrington Reports Third Quarter 2007 Results 1969 6Criteria Predict Womens 5 Year Risk for Fracture 7028 1Criteria Predict Womens 5 Year Risk for Fracture 7028 2Blood vessel blocker aids cancer killing virus 7025 1Blood vessel blocker aids cancer killing virus 7025 2[0] Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists[0] Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine[0] Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions[0] New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
...LES--(BUSINESS WIRE)--Jun 4, 2007 - Cougar Biotech...sitive interim Phase I,and Phase II data on the Co...raterone acetate) was presented at the American So...which is currently,taking place in Chicago, Illino...ions on Saturday, June 2nd, as part of the poster,...
...s from a Children,s Oncology Group (COG) Study Pre...nual Meeting -, CHICAGO, June 04, 2007 /PRNewswire...tical company focused on developing monoclonal,ant..., today,announced that treatment with epratuzumab ...lerated in children with,B-precursor acute lymphob...
Other Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 4Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 5Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 6Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 2Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 3Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 4Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 5| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |